Health
Healthcare systems, disease, pharmaceuticals, and public health outcomes.
Hackensack Meridian Health joins Pfizer clinical trial for C. diff vaccine
Hackensack Meridian Health said it will host two Pfizer trial sites for the BEETHOVEN study of an investigational C. diff vaccine.
FDA posts nationwide recall of Blaine Labs wound care gels
The FDA posted a nationwide recall of Blaine Labs wound care gels after testing found Lysinibacillus fusiformis contamination in three lots.
FDA flags Revitaderm and Tridergel antiseptic wound care gels in fresh recall alert
The FDA posted a recall alert for Blaine Labs wound care gels after testing found Lysinibacillus fusiformis contamination in Revitaderm and Tridergel.
'Month of worry' over doctor strike surgery delay
BBC reports that Tom Lawson’s gastric bypass surgery has been delayed again because of the resident doctors’ strike in England.
Telix posts Q1 2026 commercial and operational update
Telix reported strong Q1 2026 revenue growth, reaffirmed full-year guidance and highlighted progress across its therapeutics pipeline.
UT Health San Antonio reports navigated TMS reduced combat PTSD symptoms
UT Health San Antonio says navigated TMS significantly reduced combat PTSD symptoms in a randomized clinical trial published in JAMA Network Open.
FDA launches READI-Home innovation challenge for home-use medical devices
The FDA has opened a challenge for home-use medical devices aimed at reducing avoidable readmissions after hospital treatment.
NRC logs Browns Ferry Unit 3 reactor protection system actuation in April 7 event report
The NRC’s April 7 event report includes a Browns Ferry Unit 3 reactor protection system actuation, with no reported impact on public health or safety.
WHO urges science-led action and a stronger One Health approach in Timor-Leste
WHO has called for science-led policy and stronger One Health coordination in Timor-Leste, citing rabies, AMR and recent disease elimination gains.
Bangladesh ramps up emergency measles-rubella campaign as outbreak deaths top 100
Bangladesh has launched an emergency measles-rubella campaign as the outbreak worsens, with latest reporting saying more than 100 children have died.
Why are resident doctors striking and how much are they paid?
Resident doctors in England are striking this week over pay and training concerns. Government material says average full-time basic pay is about £54,300.
Cancer patient furious as strike delays appointment
A patient said he felt let down after a cardiology appointment was cancelled during the resident doctors’ strike, as NHS England says cancer and urgent care should be protected.
Optimizing Food-Is-Medicine Programs for High Blood Pressure—Reply
JAMA Internal Medicine published a reply on April 6, 2026, arguing that food-is-medicine programs for high blood pressure need stronger nutrition targets and behavioral science to work better.
/environment-climate-change-and-health-(ech)/250310laoenvi_health_336.tmb-1200v.jpg?sfvrsn=6e5f336a_8)
WHO opens One Health Summit in Lyon
WHO says the One Health Summit is underway in Lyon, with the high-level segment set for 7 April and World Health Day.
Healthcare execs cite strong job growth alongside persistent labor shortages
March labor data showed health care again leading job growth, but hospital and health system leaders say labor shortages remain most acute in direct patient care roles.
Concerns over a Nebraska hospital show how a $50B rural health fund is coming up short
AP reporting on Avera Creighton Hospital in northeast Nebraska shows how the federal Rural Health Transformation Program may not be large enough to offset broader rural hospital losses.
U.S. measles cases climb to 1,671 as Utah drives weekly increase
CDC’s latest dashboard shows 1,671 confirmed U.S. measles cases as of April 2, with Utah accounting for most of the weekly increase.
Trump imposes 100% tariff on some patented drugs
The White House said it is imposing a 100% tariff on patented pharmaceutical products and ingredients, while carving out several exemptions.
Pfizer, BioNTech halt U.S. COVID vaccine study after recruitment struggles
Pfizer and BioNTech are stopping a large U.S. phase 3 study of an updated COVID-19 vaccine in healthy adults ages 50 to 64 after slow recruitment left the trial unable to generate the data needed for the regulatory package, Reuters reported. The companies said the move was not based on safety or benefit-risk concerns and that they had notified the FDA.